Document is current
Any future updates will be listed below
-
Authors
Sun, Yanan
Liu, Dongyi
Zhang, Xiaobo
Su, Peng https://orcid.org/0000-0002-7000-0474
Li, Xin https://orcid.org/0009-0007-3315-3408
Li, Zhongbo
Gai, Yingwen
Li, Jingying
Yang, Zhiyong
Ding, Yinlu https://orcid.org/0000-0001-8111-8964
Zhu, Jian
Tan, Xiaodong https://orcid.org/0000-0003-0862-1306
- License Information
-
More Information
Article History
Received: 15 April 2024
Revised: 27 July 2024
Accepted: 6 August 2024
First Online: 14 August 2024
Competing interests
: The authors declare no competing interests.
: All authors consent to publication.
: All methods were performed in accordance with the relevant guidelines and regulations. Informed consent was obtained from all participants. Department of Laboratory Animals, China Medical University reviewed and approved this study (KT20240438). The clinical colon cancer samples were from Shanghai Outdo Biotech Company, while the Ethical Board of Shanghai Outdo Biotech Company reviewed and approved this use of clinical samples (HCol-Ade180CS-01). All patients provided written informed consent before enrollment.
